Pricing Log in Create free account

MIRA Pharmaceuticals, Inc. (MIRA) vs Scilex Holding Company (SCLX)

MIRA Pharmaceuticals, Inc. and Scilex Holding Company are both Drug Manufacturers General companies. MIRA Pharmaceuticals, Inc. is the larger, with a market value of $27.7M against $19.8M — 1.4× the size. MIRA Pharmaceuticals, Inc. has the higher net margin (0.00% vs −1,418.5%) and the lower return on invested capital (−12,016.1% vs 0.00%). Across the 12 metrics below, MIRA Pharmaceuticals, Inc. leads on 7 and Scilex Holding Company on 5.

Valuation

Metric MIRA SCLX Drug Manufacturers General median
P/E n/m n/m 24.54
P/S n/m 0.62 3.39
P/B 3.24 n/m 5.00
Price to free cash flow n/m n/m 16.55
EV/EBITDA n/m n/m 13.82
EV/Sales n/m 3.18 4.03
Earnings yield (226.03%) (1,756.18%) 2.98%
Free cash flow yield (17.52%) (91.35%) 4.46%

Profitability

Metric MIRA SCLX Drug Manufacturers General median
Gross margin — 55.50% 72.77%
Operating margin 0.00% (1,136.40%) 18.77%
Net margin 0.00% (1,418.45%) 8.27%
Free cash flow margin 0.00% (56.37%) 17.18%
Return on equity (710.85%) 160.27% 5.87%
Return on assets (684.27%) (265.83%) 2.57%
Return on invested capital (12,016.10%) 0.00% 6.11%

Growth

Metric MIRA SCLX Drug Manufacturers General median
Revenue growth (TTM) — (28.55%) 6.66%
EPS growth (last fiscal year) (164.71%) (408.32%) 21.81%
Revenue growth, 5-year CAGR — 5.13% 4.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIRA SCLX Drug Manufacturers General median
Debt to equity 0.00 (0.26) 0.63
Current ratio 200.19 0.07 1.32
Net debt to EBITDA 1.05 (0.27) 1.15

Dividend

Metric MIRA SCLX Drug Manufacturers General median
Dividend yield — — 2.33%
Payout ratio — — 0.59

Size

Metric MIRA SCLX Drug Manufacturers General median
Market cap 27.65m 19.84m 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack